Grey Matters Health Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AGNPF research report →
Price Chart
About the company
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program.
- CEO
- Christopher J. Moreau
- IPO
- 2016
- Employees
- 5
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on AGNPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-54,654+0.0%
- Op Income
- $-1,716,631
- Net Income
- $-1,715,892-241.1%
- EPS
- $-0.58-131.9%
- OCF Growth
- +57.3%
- FCF Growth
- +58.6%
- 52W High
- $0.64
- 52W Low
- $0.18
- 50D MA
- $0.28
- 200D MA
- $0.31
- Beta
- 0.29
- RSI (14)
- 25
- Avg Volume
- 5.13K
No earnings-call transcripts are available for AGNPF yet.
- Free Float
- 75.7%
- Shares Outstanding
- 8.92M
- Float Shares
- 6.75M
Our AGNPF coverage
Recent articles, reports, and earnings notes.
No research on AGNPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AGNPF report →Grey Matters Announces Accreditation for its Flagship NovaScan Neuroimaging Clinics™ Location in Florida and Completes Medicare and Medicaid Enrollment
globenewswire.com · Nov 16
Grey Matters Announces an Increase to its Equity and Convertible Debenture Private Placement to CAD $1.1 Million
globenewswire.com · Sep 16
Grey Matters Achieves Final Major Milestone; Receives Radioactive Materials License from State of Florida for its Flagship NovaScan Neuroimaging Clinics™ Location
globenewswire.com · Aug 20
Grey Matters Announces CAD $800K of Private Placement Equity Financing and Convertible Debentures
globenewswire.com · Aug 20
Grey Matters Retains Nationally Recognized ProScan to Read Brain Images from its Flagship NovaScan Neuroimaging Clinics™ Location in Florida
globenewswire.com · Aug 19
Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.
globenewswire.com · Aug 4
Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida
globenewswire.com · Jul 6
Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering
globenewswire.com · Jun 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.